Human genital antibody-mediated inhibition of Chlamydia trachomatis infection and evidence for ompA genotype-specific neutralization
The endocervix, the primary site of Chlamydia trachomatis (Ct) infection in women, has a unique repertoire of locally synthesized IgG and secretory IgA (SIgA) with contributions from serum IgG. Here, we assessed the ability of genital and serum-derived IgG and IgA from women with a recent positive C...
Gespeichert in:
Veröffentlicht in: | PloS one 2021-10, Vol.16 (10), p.e0258759-e0258759 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e0258759 |
---|---|
container_issue | 10 |
container_start_page | e0258759 |
container_title | PloS one |
container_volume | 16 |
creator | Ardizzone, Caleb M Albritton, Hannah L Lillis, Rebecca A Bagnetto, Caitlyn E. L Shen, Li Cavacini, Lisa A Kozlowski, Pamela A Quayle, Alison J |
description | The endocervix, the primary site of Chlamydia trachomatis (Ct) infection in women, has a unique repertoire of locally synthesized IgG and secretory IgA (SIgA) with contributions from serum IgG. Here, we assessed the ability of genital and serum-derived IgG and IgA from women with a recent positive Ct test to neutralize Ct elementary bodies (EBs) and inhibit inclusion formation in vitro in human endocervical epithelial cells. We also determined if neutralization was influenced by the major outer membrane protein (MOMP) of the infecting strain, as indicated by ompA gene sequencing and genotyping. At equivalent low concentrations of Ct EB (D/UW-3/Cx + E/UW-5/Cx)-specific antibody, genital-derived IgG and IgA and serum IgA, but not serum IgG, significantly inhibited inclusion formation, with genital IgA being most effective, followed by genital IgG, then serum IgA. The well-characterized Ct genotype D strain, D/UW-3/Cx, was neutralized by serum-derived IgG from patients infected with genotype D strains, genital IgG from patients infected with genotype D or E strains, and by genital IgA from patients infected with genotype D, E, or F strains. Additionally, inhibition of D/UW-3/Cx infection by whole serum, rather than purified immunoglobulin, was associated with levels of serum EB-specific IgG rather than the genotype of infecting strain. In contrast, a Ct genotype Ia clinical isolate, Ia/LSU-56/Cx, was neutralized by whole serum in a genotype and genogroup-specific manner, and inhibition also correlated with EB-specific IgG concentrations in serum. Taken together, these data suggest that (i) genital IgA most effectively inhibits Ct infection in vitro, (ii) human antibody-mediated inhibition of Ct infection is significantly influenced by the ompA genotype of the infecting strain, (iii) the genital antibody repertoire develops or matures differently compared to systemic antibody, and (iv) ompA genotype-specificity of inhibition of infection by whole serum can be overcome by high concentrations of Ct-specific IgG. |
doi_str_mv | 10.1371/journal.pone.0258759 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2583059620</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A679344322</galeid><doaj_id>oai_doaj_org_article_78ad922d8fe74b849db5899f1873ae40</doaj_id><sourcerecordid>A679344322</sourcerecordid><originalsourceid>FETCH-LOGICAL-c669t-5c47ccf1d54763d1de71ad6aee55baf697750e34834d7f3f7ad31060512ef3d33</originalsourceid><addsrcrecordid>eNqNk12L1DAUhoso7jr6DwQLguhFx7ZpmvZGGAZ1BxYW_LoNp8nJNEubjE26OF77w013qmxlLyQXCclz3uS8JyeKnmfpOiMse3ttx8FAtz5Yg-s0pxWj9YPoPKtJnpR5Sh7eWZ9FT5y7TlNKqrJ8HJ2RoixzQrPz6NfF2IOJ92i0hy4G43Vj5THpUWrwKGNtWt1or62JrYq3bQf9MRzFfgDR2h68doFRKG4RMDLGGy3RCIyVHWLbHzaTuvXHAybugEIrLWKDYxDo9E-Ywp5GjxR0Dp_N8yr6-uH9l-1Fcnn1cbfdXCaiLGufUFEwIVQmacFKIjOJLANZAiKlDaiyZoymSIqKFJIpohhIkqVlSrMcFZGErKIXJ91DZx2fDXQ8eEdSWk9GraLdiZAWrvlh0D0MR25B89sNO-w5DF6LDjmrQNZ5LiuFrGiqopYNrepaZRUjgMWk9W6-bWyCnQLNlPJCdHlidMv39oZXNCdpqM8qej0LDPb7iM7zXjuBXQcG7Xh6d1HkKZvQl_-g92c3U3sICYSq2amKkyjflKwOYiSftNb3UGFI7LUIv03psL8IeLMICIzHH34Po3N89_nT_7NX35bsqztsi9D51tlunL6MW4LFCRSDdW5A9dfkLOVTs_xxg0_NwudmIb8BIXcH3A</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2583059620</pqid></control><display><type>article</type><title>Human genital antibody-mediated inhibition of Chlamydia trachomatis infection and evidence for ompA genotype-specific neutralization</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Ardizzone, Caleb M ; Albritton, Hannah L ; Lillis, Rebecca A ; Bagnetto, Caitlyn E. L ; Shen, Li ; Cavacini, Lisa A ; Kozlowski, Pamela A ; Quayle, Alison J</creator><creatorcontrib>Ardizzone, Caleb M ; Albritton, Hannah L ; Lillis, Rebecca A ; Bagnetto, Caitlyn E. L ; Shen, Li ; Cavacini, Lisa A ; Kozlowski, Pamela A ; Quayle, Alison J</creatorcontrib><description>The endocervix, the primary site of Chlamydia trachomatis (Ct) infection in women, has a unique repertoire of locally synthesized IgG and secretory IgA (SIgA) with contributions from serum IgG. Here, we assessed the ability of genital and serum-derived IgG and IgA from women with a recent positive Ct test to neutralize Ct elementary bodies (EBs) and inhibit inclusion formation in vitro in human endocervical epithelial cells. We also determined if neutralization was influenced by the major outer membrane protein (MOMP) of the infecting strain, as indicated by ompA gene sequencing and genotyping. At equivalent low concentrations of Ct EB (D/UW-3/Cx + E/UW-5/Cx)-specific antibody, genital-derived IgG and IgA and serum IgA, but not serum IgG, significantly inhibited inclusion formation, with genital IgA being most effective, followed by genital IgG, then serum IgA. The well-characterized Ct genotype D strain, D/UW-3/Cx, was neutralized by serum-derived IgG from patients infected with genotype D strains, genital IgG from patients infected with genotype D or E strains, and by genital IgA from patients infected with genotype D, E, or F strains. Additionally, inhibition of D/UW-3/Cx infection by whole serum, rather than purified immunoglobulin, was associated with levels of serum EB-specific IgG rather than the genotype of infecting strain. In contrast, a Ct genotype Ia clinical isolate, Ia/LSU-56/Cx, was neutralized by whole serum in a genotype and genogroup-specific manner, and inhibition also correlated with EB-specific IgG concentrations in serum. Taken together, these data suggest that (i) genital IgA most effectively inhibits Ct infection in vitro, (ii) human antibody-mediated inhibition of Ct infection is significantly influenced by the ompA genotype of the infecting strain, (iii) the genital antibody repertoire develops or matures differently compared to systemic antibody, and (iv) ompA genotype-specificity of inhibition of infection by whole serum can be overcome by high concentrations of Ct-specific IgG.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0258759</identifier><identifier>PMID: 34662351</identifier><language>eng</language><publisher>San Francisco: Public Library of Science</publisher><subject>Analysis ; Antibiotics ; Antibodies ; Antigens ; B cells ; Bacterial infections ; Biology and Life Sciences ; Chlamydia ; Chlamydia infections ; Chlamydia trachomatis ; Diagnosis ; Epithelial cells ; Epithelium ; Gene sequencing ; Genetic aspects ; Genotype & phenotype ; Genotypes ; Genotyping ; Health sciences ; Immunoglobulin A ; Immunoglobulin G ; Immunoglobulins ; Immunology ; Infections ; Low concentrations ; Major outer membrane protein ; Medicine and Health Sciences ; Membrane proteins ; Neutralization ; OmpA protein ; Parasitology ; Patients ; Pelvic inflammatory disease ; Research and Analysis Methods ; Sexually transmitted diseases ; STD ; Strains (organisms) ; Vagina ; Viral antibodies ; Womens health</subject><ispartof>PloS one, 2021-10, Vol.16 (10), p.e0258759-e0258759</ispartof><rights>COPYRIGHT 2021 Public Library of Science</rights><rights>2021 Ardizzone et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Ardizzone et al 2021 Ardizzone et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c669t-5c47ccf1d54763d1de71ad6aee55baf697750e34834d7f3f7ad31060512ef3d33</citedby><cites>FETCH-LOGICAL-c669t-5c47ccf1d54763d1de71ad6aee55baf697750e34834d7f3f7ad31060512ef3d33</cites><orcidid>0000-0003-2313-1292 ; 0000-0002-7915-4437</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523062/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523062/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79343,79344</link.rule.ids></links><search><creatorcontrib>Ardizzone, Caleb M</creatorcontrib><creatorcontrib>Albritton, Hannah L</creatorcontrib><creatorcontrib>Lillis, Rebecca A</creatorcontrib><creatorcontrib>Bagnetto, Caitlyn E. L</creatorcontrib><creatorcontrib>Shen, Li</creatorcontrib><creatorcontrib>Cavacini, Lisa A</creatorcontrib><creatorcontrib>Kozlowski, Pamela A</creatorcontrib><creatorcontrib>Quayle, Alison J</creatorcontrib><title>Human genital antibody-mediated inhibition of Chlamydia trachomatis infection and evidence for ompA genotype-specific neutralization</title><title>PloS one</title><description>The endocervix, the primary site of Chlamydia trachomatis (Ct) infection in women, has a unique repertoire of locally synthesized IgG and secretory IgA (SIgA) with contributions from serum IgG. Here, we assessed the ability of genital and serum-derived IgG and IgA from women with a recent positive Ct test to neutralize Ct elementary bodies (EBs) and inhibit inclusion formation in vitro in human endocervical epithelial cells. We also determined if neutralization was influenced by the major outer membrane protein (MOMP) of the infecting strain, as indicated by ompA gene sequencing and genotyping. At equivalent low concentrations of Ct EB (D/UW-3/Cx + E/UW-5/Cx)-specific antibody, genital-derived IgG and IgA and serum IgA, but not serum IgG, significantly inhibited inclusion formation, with genital IgA being most effective, followed by genital IgG, then serum IgA. The well-characterized Ct genotype D strain, D/UW-3/Cx, was neutralized by serum-derived IgG from patients infected with genotype D strains, genital IgG from patients infected with genotype D or E strains, and by genital IgA from patients infected with genotype D, E, or F strains. Additionally, inhibition of D/UW-3/Cx infection by whole serum, rather than purified immunoglobulin, was associated with levels of serum EB-specific IgG rather than the genotype of infecting strain. In contrast, a Ct genotype Ia clinical isolate, Ia/LSU-56/Cx, was neutralized by whole serum in a genotype and genogroup-specific manner, and inhibition also correlated with EB-specific IgG concentrations in serum. Taken together, these data suggest that (i) genital IgA most effectively inhibits Ct infection in vitro, (ii) human antibody-mediated inhibition of Ct infection is significantly influenced by the ompA genotype of the infecting strain, (iii) the genital antibody repertoire develops or matures differently compared to systemic antibody, and (iv) ompA genotype-specificity of inhibition of infection by whole serum can be overcome by high concentrations of Ct-specific IgG.</description><subject>Analysis</subject><subject>Antibiotics</subject><subject>Antibodies</subject><subject>Antigens</subject><subject>B cells</subject><subject>Bacterial infections</subject><subject>Biology and Life Sciences</subject><subject>Chlamydia</subject><subject>Chlamydia infections</subject><subject>Chlamydia trachomatis</subject><subject>Diagnosis</subject><subject>Epithelial cells</subject><subject>Epithelium</subject><subject>Gene sequencing</subject><subject>Genetic aspects</subject><subject>Genotype & phenotype</subject><subject>Genotypes</subject><subject>Genotyping</subject><subject>Health sciences</subject><subject>Immunoglobulin A</subject><subject>Immunoglobulin G</subject><subject>Immunoglobulins</subject><subject>Immunology</subject><subject>Infections</subject><subject>Low concentrations</subject><subject>Major outer membrane protein</subject><subject>Medicine and Health Sciences</subject><subject>Membrane proteins</subject><subject>Neutralization</subject><subject>OmpA protein</subject><subject>Parasitology</subject><subject>Patients</subject><subject>Pelvic inflammatory disease</subject><subject>Research and Analysis Methods</subject><subject>Sexually transmitted diseases</subject><subject>STD</subject><subject>Strains (organisms)</subject><subject>Vagina</subject><subject>Viral antibodies</subject><subject>Womens health</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk12L1DAUhoso7jr6DwQLguhFx7ZpmvZGGAZ1BxYW_LoNp8nJNEubjE26OF77w013qmxlLyQXCclz3uS8JyeKnmfpOiMse3ttx8FAtz5Yg-s0pxWj9YPoPKtJnpR5Sh7eWZ9FT5y7TlNKqrJ8HJ2RoixzQrPz6NfF2IOJ92i0hy4G43Vj5THpUWrwKGNtWt1or62JrYq3bQf9MRzFfgDR2h68doFRKG4RMDLGGy3RCIyVHWLbHzaTuvXHAybugEIrLWKDYxDo9E-Ywp5GjxR0Dp_N8yr6-uH9l-1Fcnn1cbfdXCaiLGufUFEwIVQmacFKIjOJLANZAiKlDaiyZoymSIqKFJIpohhIkqVlSrMcFZGErKIXJ91DZx2fDXQ8eEdSWk9GraLdiZAWrvlh0D0MR25B89sNO-w5DF6LDjmrQNZ5LiuFrGiqopYNrepaZRUjgMWk9W6-bWyCnQLNlPJCdHlidMv39oZXNCdpqM8qej0LDPb7iM7zXjuBXQcG7Xh6d1HkKZvQl_-g92c3U3sICYSq2amKkyjflKwOYiSftNb3UGFI7LUIv03psL8IeLMICIzHH34Po3N89_nT_7NX35bsqztsi9D51tlunL6MW4LFCRSDdW5A9dfkLOVTs_xxg0_NwudmIb8BIXcH3A</recordid><startdate>20211018</startdate><enddate>20211018</enddate><creator>Ardizzone, Caleb M</creator><creator>Albritton, Hannah L</creator><creator>Lillis, Rebecca A</creator><creator>Bagnetto, Caitlyn E. L</creator><creator>Shen, Li</creator><creator>Cavacini, Lisa A</creator><creator>Kozlowski, Pamela A</creator><creator>Quayle, Alison J</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-2313-1292</orcidid><orcidid>https://orcid.org/0000-0002-7915-4437</orcidid></search><sort><creationdate>20211018</creationdate><title>Human genital antibody-mediated inhibition of Chlamydia trachomatis infection and evidence for ompA genotype-specific neutralization</title><author>Ardizzone, Caleb M ; Albritton, Hannah L ; Lillis, Rebecca A ; Bagnetto, Caitlyn E. L ; Shen, Li ; Cavacini, Lisa A ; Kozlowski, Pamela A ; Quayle, Alison J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c669t-5c47ccf1d54763d1de71ad6aee55baf697750e34834d7f3f7ad31060512ef3d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Analysis</topic><topic>Antibiotics</topic><topic>Antibodies</topic><topic>Antigens</topic><topic>B cells</topic><topic>Bacterial infections</topic><topic>Biology and Life Sciences</topic><topic>Chlamydia</topic><topic>Chlamydia infections</topic><topic>Chlamydia trachomatis</topic><topic>Diagnosis</topic><topic>Epithelial cells</topic><topic>Epithelium</topic><topic>Gene sequencing</topic><topic>Genetic aspects</topic><topic>Genotype & phenotype</topic><topic>Genotypes</topic><topic>Genotyping</topic><topic>Health sciences</topic><topic>Immunoglobulin A</topic><topic>Immunoglobulin G</topic><topic>Immunoglobulins</topic><topic>Immunology</topic><topic>Infections</topic><topic>Low concentrations</topic><topic>Major outer membrane protein</topic><topic>Medicine and Health Sciences</topic><topic>Membrane proteins</topic><topic>Neutralization</topic><topic>OmpA protein</topic><topic>Parasitology</topic><topic>Patients</topic><topic>Pelvic inflammatory disease</topic><topic>Research and Analysis Methods</topic><topic>Sexually transmitted diseases</topic><topic>STD</topic><topic>Strains (organisms)</topic><topic>Vagina</topic><topic>Viral antibodies</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ardizzone, Caleb M</creatorcontrib><creatorcontrib>Albritton, Hannah L</creatorcontrib><creatorcontrib>Lillis, Rebecca A</creatorcontrib><creatorcontrib>Bagnetto, Caitlyn E. L</creatorcontrib><creatorcontrib>Shen, Li</creatorcontrib><creatorcontrib>Cavacini, Lisa A</creatorcontrib><creatorcontrib>Kozlowski, Pamela A</creatorcontrib><creatorcontrib>Quayle, Alison J</creatorcontrib><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ardizzone, Caleb M</au><au>Albritton, Hannah L</au><au>Lillis, Rebecca A</au><au>Bagnetto, Caitlyn E. L</au><au>Shen, Li</au><au>Cavacini, Lisa A</au><au>Kozlowski, Pamela A</au><au>Quayle, Alison J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human genital antibody-mediated inhibition of Chlamydia trachomatis infection and evidence for ompA genotype-specific neutralization</atitle><jtitle>PloS one</jtitle><date>2021-10-18</date><risdate>2021</risdate><volume>16</volume><issue>10</issue><spage>e0258759</spage><epage>e0258759</epage><pages>e0258759-e0258759</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>The endocervix, the primary site of Chlamydia trachomatis (Ct) infection in women, has a unique repertoire of locally synthesized IgG and secretory IgA (SIgA) with contributions from serum IgG. Here, we assessed the ability of genital and serum-derived IgG and IgA from women with a recent positive Ct test to neutralize Ct elementary bodies (EBs) and inhibit inclusion formation in vitro in human endocervical epithelial cells. We also determined if neutralization was influenced by the major outer membrane protein (MOMP) of the infecting strain, as indicated by ompA gene sequencing and genotyping. At equivalent low concentrations of Ct EB (D/UW-3/Cx + E/UW-5/Cx)-specific antibody, genital-derived IgG and IgA and serum IgA, but not serum IgG, significantly inhibited inclusion formation, with genital IgA being most effective, followed by genital IgG, then serum IgA. The well-characterized Ct genotype D strain, D/UW-3/Cx, was neutralized by serum-derived IgG from patients infected with genotype D strains, genital IgG from patients infected with genotype D or E strains, and by genital IgA from patients infected with genotype D, E, or F strains. Additionally, inhibition of D/UW-3/Cx infection by whole serum, rather than purified immunoglobulin, was associated with levels of serum EB-specific IgG rather than the genotype of infecting strain. In contrast, a Ct genotype Ia clinical isolate, Ia/LSU-56/Cx, was neutralized by whole serum in a genotype and genogroup-specific manner, and inhibition also correlated with EB-specific IgG concentrations in serum. Taken together, these data suggest that (i) genital IgA most effectively inhibits Ct infection in vitro, (ii) human antibody-mediated inhibition of Ct infection is significantly influenced by the ompA genotype of the infecting strain, (iii) the genital antibody repertoire develops or matures differently compared to systemic antibody, and (iv) ompA genotype-specificity of inhibition of infection by whole serum can be overcome by high concentrations of Ct-specific IgG.</abstract><cop>San Francisco</cop><pub>Public Library of Science</pub><pmid>34662351</pmid><doi>10.1371/journal.pone.0258759</doi><tpages>e0258759</tpages><orcidid>https://orcid.org/0000-0003-2313-1292</orcidid><orcidid>https://orcid.org/0000-0002-7915-4437</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2021-10, Vol.16 (10), p.e0258759-e0258759 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_2583059620 |
source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS) |
subjects | Analysis Antibiotics Antibodies Antigens B cells Bacterial infections Biology and Life Sciences Chlamydia Chlamydia infections Chlamydia trachomatis Diagnosis Epithelial cells Epithelium Gene sequencing Genetic aspects Genotype & phenotype Genotypes Genotyping Health sciences Immunoglobulin A Immunoglobulin G Immunoglobulins Immunology Infections Low concentrations Major outer membrane protein Medicine and Health Sciences Membrane proteins Neutralization OmpA protein Parasitology Patients Pelvic inflammatory disease Research and Analysis Methods Sexually transmitted diseases STD Strains (organisms) Vagina Viral antibodies Womens health |
title | Human genital antibody-mediated inhibition of Chlamydia trachomatis infection and evidence for ompA genotype-specific neutralization |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T19%3A27%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20genital%20antibody-mediated%20inhibition%20of%20Chlamydia%20trachomatis%20infection%20and%20evidence%20for%20ompA%20genotype-specific%20neutralization&rft.jtitle=PloS%20one&rft.au=Ardizzone,%20Caleb%20M&rft.date=2021-10-18&rft.volume=16&rft.issue=10&rft.spage=e0258759&rft.epage=e0258759&rft.pages=e0258759-e0258759&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0258759&rft_dat=%3Cgale_plos_%3EA679344322%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2583059620&rft_id=info:pmid/34662351&rft_galeid=A679344322&rft_doaj_id=oai_doaj_org_article_78ad922d8fe74b849db5899f1873ae40&rfr_iscdi=true |